ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 190 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $37,317 | -87.5% | 6,847 | -84.6% | 0.00% | – |
Q2 2023 | $298,011 | +234.9% | 44,413 | +340.7% | 0.00% | – |
Q1 2023 | $88,988 | -8.5% | 10,078 | -20.8% | 0.00% | – |
Q4 2022 | $97,242 | -3.7% | 12,728 | -10.1% | 0.00% | – |
Q3 2022 | $101,000 | -51.2% | 14,157 | -44.7% | 0.00% | – |
Q2 2022 | $207,000 | -47.5% | 25,604 | -9.8% | 0.00% | – |
Q1 2022 | $394,000 | -42.3% | 28,375 | +16.6% | 0.00% | – |
Q4 2021 | $683,000 | -33.4% | 24,328 | -19.4% | 0.00% | -100.0% |
Q3 2021 | $1,026,000 | -29.1% | 30,176 | -14.9% | 0.00% | 0.0% |
Q2 2021 | $1,448,000 | +39.5% | 35,446 | +37.4% | 0.00% | 0.0% |
Q1 2021 | $1,038,000 | -41.3% | 25,791 | -13.7% | 0.00% | 0.0% |
Q4 2020 | $1,767,000 | +15.9% | 29,877 | -4.7% | 0.00% | 0.0% |
Q3 2020 | $1,524,000 | -6.3% | 31,338 | -6.7% | 0.00% | 0.0% |
Q2 2020 | $1,626,000 | -58.3% | 33,592 | -76.1% | 0.00% | -75.0% |
Q1 2020 | $3,901,000 | -7.1% | 140,434 | +0.0% | 0.00% | +33.3% |
Q4 2019 | $4,201,000 | +183.7% | 140,421 | +192.9% | 0.00% | +200.0% |
Q3 2019 | $1,481,000 | – | 47,935 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
Triatomic Management LP | 102,889 | $560,745 | 0.39% |